Karanovic & Partners advised Precision for Medicine, part of the Precision Medicine Group, on its’ cross-border acquisition of Argint International. The transaction is part of Precision’s global growth plan, and the company’s European footprint now includes offices in Edinburgh, Paris, Berlin, Geneva, Budapest, Bucharest, Bratislava, and Belgrade.
The Karanovic & Partners legal team was led by Partner Miloš Jakovljević and Senior Associate and healthcare specialist Milica Filipović, with Associates Sava Drača and Srđan Šijakinjić. The services performed include general corporate advisory on the Serbian aspects of this multijurisdictional acquisition, legal due diligence and the preparation of the SPA.
Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively. Precision applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology, focusing predominantly on genomics, immune-response assays, global specimen logistics, biomarker analytics, companion diagnostics, and clinical trial execution. Precision for Medicine is part of Precision Medicine Group, with more than 1,450 employees in 25 locations in the US, Canada, and Europe.
